IP Library Granted Patent US 7,229,841
Granted Patent B2
US 7,229,841 · App. 10/093,578 · Granted Jun 12, 2007

Colloidal metal compositions and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,229,841
App. No.
10/093,578
Granted
Jun 12, 2007
Kind
B2
Abstract

The present invention comprises compositions and methods for delivery systems of agents, including therapeutic compounds, pharmaceutical agents, drugs, detection agents, nucleic acid sequences and biological factors. In general, these vector compositions comprise a colloidal metal, derivatized PEG (polyethylene glycol) and an agent. The invention also comprises methods and compositions for making such colloidal metal compositions and for treatment of cancer.

Claims (8)

1. A composition comprising a pegylated colloidal gold particle, wherein a polyethylene glycol derivative is covalently bound to the colloidal gold particle.

2. The composition of claim 1 , further comprising an anticancer therapeutic agent.

3. The composition of claim 2 , wherein the anti-cancer therapeutic agent comprises endostatin, angiostatin, thalidomide, taxol, melphalan, paclitaxel, taxanes, vinblastin, vincristine, doxorubicin, tumor necrosis factor, acyclovir, cisplatin or tacrine.

4. The composition of claim 1 , further comprising a targeting molecule.

5. The composition of claim 1 , further comprising an integrating molecule.

6. The composition of claim 1 , wherein the polyethylene glycol derivative is a polyethylene glycol-thiol derivative.

7. The composition of claim 1 , further comprising an immunostimulating molecule.

8. The composition of claim 7 , wherein the immunostimulating molecule is selected from the group consisting of Interleukin-1, Interleukin-2, Interleukin-3, Interleukin-4, Interleukin-5, Interleukin-6, Interleukin-7, Interleukin-8, Interleukin-10, Interleukin-11, Interleukin-12, Interleukin-13, lipid A, phospholipase A2, endotoxins, staphylococcal enterotoxin B, Type I Interferon, Type II Interferon, Tumor Necrosis Factor alpha, Transforming Growth Factor beta, Lymphotoxin, Migration Inhibition Factor, Granulocyte-Macrophage Colony-Stimulating Factor, Monocyte-Macrophage Colony-Stimulating Factor, Granulocyte Colony-Stimulating Factor, Angiogenin, transforming growth factor alpha, fibroblast growth factor, cancer cell specific antigens, MART, MAGE, RAGE, B7 family of molecules and receptors, CD40 ligand/receptor, basic fibroblast growth factor, and vascular endothelial growth factor.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2024
From: CYTIMMUNE SCIENCES, INC.
To: ZAHAV BIOSCIENCES LLC
Reel/Frame 066259/0708 →
RELEASE OF SECURITY INTEREST Recorded Sep 5, 2014
From: ITANI, HIDETAKA KENTARO
To: CYTIMMUNE SCIENCES, INC.
Reel/Frame 033692/0418 →
SECURITY AGREEMENT Recorded Sep 18, 2009
From: CYTIMMUNE SCIENCES, INC.
To: ITANI, HIDETAKA KENTARO
Reel/Frame 023254/0076 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2002
From: TAMARKIN, LAWRENCE; PACIOTTI, GIULIO F.
To: CYTIMMUNE SCIENCES, INC.
Reel/Frame 013109/0667 →